USPTO serial 90764926
PACT
Reviewed by CopyMark Law Group
Reg. 6629285Status 711
- Filing date
- Status date
- Registration date
- Jan 25, 2022
- Examiner
- BENMAMAN, ALICE
- Law office
- TMO LAW OFFICE 116
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with PACT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
South San Francisco, CA
South San Francisco, CA
South San Francisco, CA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Cara R. Baer
Cara R. Baer BUTLER SNOW LLP6075 POPLAR AVE, SUITE 500MEMPHIS, TN 38119UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | pharmaceutical preparations and substances for the treatment of genetic diseases, immunological diseases and cancer; personalized cell therapies for medical use for the treatment of cancer; biological preparations for medical purposes, namely, in the field of personalized cell therapies for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; anti-cancer preparations; pharmaceuticals, namely, immunotherapies for the treatment of cancer; oncological preparations, namely, pharmaceutical products for the detection and treatment of cancer; biological preparations for the treatment of cancer and oncological conditions; pharmaceutical products for the treatment of cancer and oncological conditions; none of the foregoing for use in connection with patient self-management, pain management or substance misuse | SECTION 7(e) - CANCELLED | Jun 21, 2017 |
| 040 | Bio-manufacturing for others, namely, manufacturing of adoptive cell and personalized adoptive cell therapies; none of the foregoing for use in connection with patient self-management, pain management or substance misuse | SECTION 7(e) - CANCELLED | Jun 21, 2017 |
| 042 | design of personalized adoptive cell therapies for others; none of the foregoing for use in connection with patient self-management, pain management or substance misuse | SECTION 7(e) - CANCELLED | Jun 21, 2017 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by PACT Pharma, Inc.
- Other trademarks owned by PACT Pharma, Inc.
- Other trademarks owned by PACT Pharma, Inc.
- Other trademarks in Class 005
- Other trademarks in Class 040
- Other trademarks in Class 042
- Similar marks named PACT
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 27, 2024 | NCS7 | NOTICE OF CANCELLATION SEC. 7 SURRENDER EMAILED | — |
| Feb 26, 2024 | C7.. | CANCELLED SECTION 7-TOTAL | — |
| Feb 21, 2024 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jun 16, 2023 | C7RF | REQUEST FOR SECT 7 TOTAL SURRENDER FILED | — |
| Jun 16, 2023 | ES7S | TEAS SECTION 7 SURRENDER RECEIVED | — |
| Jan 25, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 9, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 9, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 20, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 5, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 29, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 28, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 28, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 27, 2021 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 27, 2021 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 27, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 27, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 31, 2021 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Aug 30, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 12, 2021 | NWAP | NEW APPLICATION ENTERED | — |